Thank you for your interest, we’ll get in touch with you shortly!

Du använder Internet Explorer, en webbläsare som slutade utvecklas 6 november 2013, för över 10 år sedan. Den 31 januari 2020 upphörde även alla säkerhetsuppdateringar vilket innebär att webbläsaren, förutom funktionella och utseendemässiga brister även kan utgöra en säkerhetsrisk. Du rekommenderas starkt att uppgradera till en modernare webbläsare, t ex Google Chrome, Mozilla Firefox eller Microsoft Edge. Tala med din systemadministratör.
Visa inte detta meddelande igen

JE utveckling och förvaltning

Publicerad: 11 april, 2024 av susanne hertzberg |

Mindfulnesscenter

Publicerad: 11 januari, 2024 av susanne hertzberg |

Navari Surgical

Publicerad: 29 november, 2023 av susanne hertzberg |

Kongsberg Beam Technology

Publicerad: 29 november, 2023 av susanne hertzberg |

HoloCare

Publicerad: 29 november, 2023 av susanne hertzberg |

Diagonal Bio

Publicerad: 29 november, 2023 av susanne hertzberg |

Cystotech

Publicerad: 29 november, 2023 av susanne hertzberg |

Edwoak Life Science

Publicerad: 16 maj, 2023 av Elida Cimic |

Edwoak Life Science’s vision is to create a more healthy and sustainable society through innovation and digitization! Welfare actors today have major challenges with reduced financial resources and recruitment of personnel. Because of this, the collaborative work between the actors needs to be made more efficient. Our digital planning and communication tool is there to address this and make a real difference to people’s health and society’s sustainability.

Second Opinion

Publicerad: 30 augusti, 2022 av Elida Cimic |

Second Opinion is an AI-based software where the patient can seek a new medical second opinion from an independent doctor or specialist. This makes it possible to identify diagnostic errors and prevent harmful and unnecessary treatments for the patient. A second opinion contributes to an informed and empowered patient who is more involved in their healthcare journey.

Mantis Photonics

Publicerad: 28 december, 2021 av Elida Cimic |

Early screening is a major issue with alzheimer disease. Indeed, currently patients often get diagnosed too late, once they have cognitive impairment. As a result, treatments are less efficient and cannot repair the damage already caused by the disease. At Mantis Photonics, we have developed a patented hyperspectral camera that can detect biomarkers of alzheimer in the retina. This will be used as a non-invasive early detection tool for the screening of the population.